Active Ingredient: ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
Proprietary Name: TRI-LEGEST 21
Dosage Form; Route of Administration: TABLET; ORAL-21
Strength: 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A076405
Product Number: 001
Approval Date: Oct 26, 2007
Applicant Holder Full Name: BARR LABORATORIES INC
Marketing Status:
Discontinued
Patent and Exclusivity Information